These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 24553912)
1. GPER functions as a tumor suppressor in triple-negative breast cancer cells. Weißenborn C; Ignatov T; Ochel HJ; Costa SD; Zenclussen AC; Ignatova Z; Ignatov A J Cancer Res Clin Oncol; 2014 May; 140(5):713-23. PubMed ID: 24553912 [TBL] [Abstract][Full Text] [Related]
2. GPER functions as a tumor suppressor in MCF-7 and SK-BR-3 breast cancer cells. Weißenborn C; Ignatov T; Poehlmann A; Wege AK; Costa SD; Zenclussen AC; Ignatov A J Cancer Res Clin Oncol; 2014 Apr; 140(4):663-71. PubMed ID: 24515910 [TBL] [Abstract][Full Text] [Related]
3. Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer. Liu Q; Chen Z; Jiang G; Zhou Y; Yang X; Huang H; Liu H; Du J; Wang H Mol Cancer; 2017 May; 16(1):87. PubMed ID: 28476123 [TBL] [Abstract][Full Text] [Related]
4. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells. Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276 [TBL] [Abstract][Full Text] [Related]
5. NHERF1 inhibits proliferation of triple-negative breast cancer cells by suppressing GPER signaling. Wang Y; Peng Z; Meng R; Tao T; Wang Q; Zhao C; Liu H; Song R; Zheng J; Qin Q; He J Oncol Rep; 2017 Jul; 38(1):221-228. PubMed ID: 28535016 [TBL] [Abstract][Full Text] [Related]
6. GPER Promoter Methylation Controls GPER Expression in Breast Cancer Patients. Weissenborn C; Ignatov T; Nass N; Kalinski T; Dan Costa S; Zenclussen AC; Ignatov A Cancer Invest; 2017 Feb; 35(2):100-107. PubMed ID: 28118074 [TBL] [Abstract][Full Text] [Related]
7. Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells. Rigiracciolo DC; Santolla MF; Lappano R; Vivacqua A; Cirillo F; Galli GR; Talia M; Muglia L; Pellegrino M; Nohata N; Di Martino MT; Maggiolini M J Exp Clin Cancer Res; 2019 Feb; 38(1):58. PubMed ID: 30728047 [TBL] [Abstract][Full Text] [Related]
9. G protein-coupled estrogen receptor (GPER) expression in endometrial adenocarcinoma and effect of agonist G-1 on growth of endometrial adenocarcinoma cell lines. Skrzypczak M; Schüler S; Lattrich C; Ignatov A; Ortmann O; Treeck O Steroids; 2013 Nov; 78(11):1087-91. PubMed ID: 23921077 [TBL] [Abstract][Full Text] [Related]
10. SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer. Santolla MF; Avino S; Pellegrino M; De Francesco EM; De Marco P; Lappano R; Vivacqua A; Cirillo F; Rigiracciolo DC; Scarpelli A; Abonante S; Maggiolini M Cell Death Dis; 2015 Jul; 6(7):e1834. PubMed ID: 26225773 [TBL] [Abstract][Full Text] [Related]
11. Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals. Liang S; Chen Z; Jiang G; Zhou Y; Liu Q; Su Q; Wei W; Du J; Wang H Cancer Lett; 2017 Feb; 386():12-23. PubMed ID: 27836733 [TBL] [Abstract][Full Text] [Related]
12. Regulation of ERRalpha gene expression by estrogen receptor agonists and antagonists in SKBR3 breast cancer cells: differential molecular mechanisms mediated by g protein-coupled receptor GPR30/GPER-1. Li Y; Birnbaumer L; Teng CT Mol Endocrinol; 2010 May; 24(5):969-80. PubMed ID: 20211987 [TBL] [Abstract][Full Text] [Related]
13. G protein-coupled estrogen receptor 1 (GPER-1) and agonist G-1 inhibit growth of ovarian cancer cells by activation of anti-tumoral transcriptome responses: impact of GPER-1 mRNA on survival. Schüler-Toprak S; Skrzypczak M; Ignatov T; Ignatov A; Ortmann O; Treeck O J Cancer Res Clin Oncol; 2020 Dec; 146(12):3175-3188. PubMed ID: 32813115 [TBL] [Abstract][Full Text] [Related]
14. G protein-coupled estrogen receptor 1 agonist G-1 induces cell cycle arrest in the mitotic phase, leading to apoptosis in endometriosis. Mori T; Ito F; Matsushima H; Takaoka O; Tanaka Y; Koshiba A; Kusuki I; Kitawaki J Fertil Steril; 2015 May; 103(5):1228-35.e1. PubMed ID: 25724739 [TBL] [Abstract][Full Text] [Related]
15. Pyoluteorin induces cell cycle arrest and apoptosis in human triple-negative breast cancer cells MDA-MB-231. Ding T; Yang LJ; Zhang WD; Shen YH J Pharm Pharmacol; 2020 Jul; 72(7):969-978. PubMed ID: 32246778 [TBL] [Abstract][Full Text] [Related]
16. Activation of GPER suppresses epithelial mesenchymal transition of triple negative breast cancer cells via NF-κB signals. Chen ZJ; Wei W; Jiang GM; Liu H; Wei WD; Yang X; Wu YM; Liu H; Wong CK; Du J; Wang HS Mol Oncol; 2016 Jun; 10(6):775-88. PubMed ID: 26842883 [TBL] [Abstract][Full Text] [Related]
17. The G-Protein-Coupled Estrogen Receptor (GPER) Regulates Trimethylation of Histone H3 at Lysine 4 and Represses Migration and Proliferation of Ovarian Cancer Cells In Vitro. Han N; Heublein S; Jeschke U; Kuhn C; Hester A; Czogalla B; Mahner S; Rottmann M; Mayr D; Schmoeckel E; Trillsch F Cells; 2021 Mar; 10(3):. PubMed ID: 33799631 [TBL] [Abstract][Full Text] [Related]
18. G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1. Liu C; Liao Y; Fan S; Tang H; Jiang Z; Zhou B; Xiong J; Zhou S; Zou M; Wang J Med Oncol; 2015 Apr; 32(4):104. PubMed ID: 25744245 [TBL] [Abstract][Full Text] [Related]
19. Activation of G-protein coupled estrogen receptor inhibits the proliferation of cervical cancer cells via sustained activation of ERK1/2. Zhang Q; Wu YZ; Zhang YM; Ji XH; Hao Q Cell Biochem Funct; 2015 Apr; 33(3):134-42. PubMed ID: 25753185 [TBL] [Abstract][Full Text] [Related]
20. Estrogen-mediated inactivation of FOXO3a by the G protein-coupled estrogen receptor GPER. Zekas E; Prossnitz ER BMC Cancer; 2015 Oct; 15():702. PubMed ID: 26470790 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]